At Paragon BioTeck Inc., we strive to develop and foster an unparalleled network of collaborative partnerships to facilitate a cooperative approach to discovery. Our partners have longstanding reputations in healthcare and each lend a unique area of expertise in contributing to the worldwide fight to prevent blindness; our livelihood is cultivated by our synergies. Through extensive research and compelling innovations, we are committed to the delivery of high-quality products, keeping patient safety central to our corporate initiatives. We understand our position as a trusted market leader and dictate our evolution with that conscience in mind.
Drive innovations to address unmet and underserved medical needs and improve the quality of lives around the world.
Bring a forward-thinking and entrepreneurial approach to developing and improving products, processes and technologies that address unmet and underserved needs and create positive change for physicians and their patients.
We have developed and refined a business model that draws from the insight and intellect of some of the greatest scientists, clinicians, regulatory experts and creative corporate leaders in eye care. This previously untapped exchange of experiential information is the driving force of our impactful innovation and operational excellence. With the implementation of these understandings and perspectives we are able to focus on the most important endpoint of our efforts, the quality of patient care provided through the Paragon BioTeck product portfolio.
– Patrick H. Witham, President & CEO
As a pharmaceutical and medical device firm, Paragon BioTeck is leading the way in the fight to prevent blindness through the development of new diagnostic and therapeutic solutions. However, there is much more to our organization than just corporate goals.
We have organized our philanthropic efforts into an initiative we call Paragon Gives. Through Paragon Gives, we strive to make a positive difference in the community around us and the world as a whole. We are committed to sustaining and expanding our philanthropic efforts as our organization continues its growth.
At Paragon BioTeck, Inc., our commitment to eye care is simple – We continually seek to elevate the industry wide standard of care through the scientific exploration and invention of original proprietary products.
Our product portfolio consists of branded over the counter (OTC) and prescription (Rx) solutions for the diagnosis, management and treatment of ocular conditions including dry eye and eyelid hygiene.
An Informed choice: Our FDA-approved Phenylephrine Hydrochloride Ophthalmic Solution, USP 2.5% and 10% is an alpha-1 adrenergic receptor agonist used for dilation of the pupil due to its vasoconstrictor and mydriatic action. Available exclusively through Bausch + Lomb.
Please contact your wholesaler for purchase information.
DID YOU KNOW?
Untreated, excessive Dry Eye Disease can damage the eye’s delicate tissues and disrupt the cornea, which can ultimately lead to vision impairment or even loss.